Personalized Radiation Therapy for Cancers: Current Status and Future Perspectives
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Methodology, Drug and Device Discovery".
Deadline for manuscript submissions: 10 January 2025 | Viewed by 38
Special Issue Editors
Interests: radiation oncology; personalized oncology; radiomics; stereotactic radiotherapy; breast cancer; prostate cancer; head and neck cancer
2. Department of Medicine and Surgery, LUM University, 70010 Bari, Italy
Interests: radiation oncology; personalized oncology; stereotactic radiotherapy; reirradiation; neuro-oncology; breast cancer; prostate cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In the era of personalized oncology, a significant improvement in patient outcomes has been achieved thanks to a favorable combination of modern knowledge on cancer (i.e., cancer-related genomic and immunological profiles, tumor microenvironment of the primary and metastatic sites, clinicopathological and imaging features predictive of clinical outcomes), technological advances in the diagnostic and radiation oncology fields, as well as recent insights in radiobiology.
Nowadays, a multidisciplinary, integrated approach to cancer patients leads to selecting treatments according to disease-specific proliferating pathways and obtaining synergistic effects between radiotherapy and immunotherapy or targeted therapies.
Furthermore, modern radiation oncology allows higher conformity treatments, adaptive approaches, and salvage/ablative re-irradiation of recurrences, with a significant impact on disease control and patients' quality of life.
This Special Issue will address the current advances and future perspectives in the field of personalized radiation oncology, underscoring the relevance of multidisciplinary evaluations to improve tailored treatments and enhance cancer patients’ outcomes.
Dr. Roberta Carbonara
Dr. Alba Fiorentino
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized radiotherapy
- personalized oncology
- adaptive radiotherapy
- stereotactic radiotherapy
- re-irradiation
- immuno-radiotherapy
- tumor microenvironment and radiotherapy
